Smau is the matching platform for innovation and professional continuous training. For over 50 years, Smau supports Italian companies and professionals to innovate, and it is an opportunity for entrepreneurs, managers, companies, and public administrations to grow up and to catch up on innovation, technology, and ICT. Smau is a national event roadshow helping public actors and companies willing to look beyond the present and opportunities offered by new technologies, digital world, and most promising start ups.
The event of this year is also dedicated to the synergies among research centres, companies and public funding in the Life Sciences areas as experienced in Fas Salute 2014 Call of Tuscany Region which UNAVIR is belonging to.
UNAVIR is a project aimed at identifying new therapeutic treatments for rare viral infections, such as Dengue, Chikungunya and West Nile and brings together Universities of Siena, Pisa, and Florence and companies, Lead Discovery Siena and VisMederi, to develop innovative treatments of personalised medicine. LDS will contribute to the projects by supporting the design, synthesis and ADMET characterization of new molecular entities active against these virues.
Maurizio Botta, LDS CEO, was the rapporteur on this project at Smau Florence to show its background, the research strategy and its potentialities.